Project Number 1R44AG49510-01 Agency/Funding Organization NIA Funding Year 2015 View Full Project Details for CLINICAL EVALUATION OF T3D-959 AS A POTENTIAL DISEASE REMEDIAL THERAPEUTIC FOR THE TREATMENT OF ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator DIDSBURY, JOHN Principal Investigator First Name JOHN Principal Investigator Last Name DIDSBURY Awardee Organization T3D THERAPEUTICS, INC. Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development FY Overall Cost $1,127,955 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
